This Continuing Education activity is supported by an educational grant from Sandoz Inc.
Jeffrey D. Dunn, PharmD, MBA
Advertisement
Articles by Jeffrey D. Dunn, PharmD, MBA
Patients, payers, providers, and employers are affected by misdiagnosis, undertreatment, and inappropriate management of migraine.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
EPCORE DLBCL-1 Trial Demonstrates Durable Responses, PFS Benefit With Epcoritamab in RR LBCL
2
FDA Adds a New Sunscreen to the OTC Repertoire
3
FDA Approves Capivasertib Plus Abiraterone and Prednisone for Prostate Cancer
4
OTC Guide: Thirty Years Strong
5